Personalised and precision medicine
Tumor heterogeneity limits drug efficacy. The CERO 3D Incubator & Bioreactor grows primary tumor cells from fresh biopsies reproducibly in 3D — the basis for patient-specific therapy testing.
Advances in molecular targeted therapies have improved outcomes in in vivo models, but tumor heterogeneity among patients often limits drug efficacy. To enhance the relevance of in vitro models, it is crucial to develop reliable platforms for cultivating primary tumor cells in 3D models, such as patient-derived xenografts or organoids. The CERO 3D Incubator & Bioreactor with its state-of-the-art dynamic culture system, accelerates precision medicine by enabling efficient and reproducible growth and maintenance of viable cancer cells in a controlled 3D environment.
CK 20 positive Cholangiocellular carcinoma cancer cells
H & E staining: Viable Cholangiocellular carcinoma cancer cells
MAPAC 155 positive cells
Invite our experts and lift your research to the next stage with a demo CERO 3D Incubator & Bioreactor from OLS
Join OLS and make your research reliable with our CERO 3D Incubator & Bioreactor with your lab-services as results.